Related Experiment Video
Updated: Sep 28, 2025

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
Published on: June 13, 2016
Metastasis prevention: targeting causes and roots
A A Schegoleva1, A A Khozyainova1, T S Gerashchenko1
1Laboratory of Cancer Progression Biology, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Kooperativny Str. 5, 634009, Tomsk, Russia.
Abstract:
The spread of tumor cells from the primary focus, metastasis, is the main cause of cancer mortality. Therefore, anticancer therapy should be focused on the prevention of metastatic disease. Key targets can be conditions in the primary tumor that are favorable for the appearance of metastatic cells and the first steps of the metastatic cascade. Here, we discuss different approaches for targeting metastasis causes (hypoxia, metabolism changes, and tumor microenvironment) and roots (angiogenesis, epithelial-mesenchymal transition, migration, and invasion). Also, we emphasize the challenges of the existing approaches for metastasis prevention and suggest opportunities to overcome them. In conclusion, we highlight the importance of clinical evaluation of the agents showing antimetastatic effects in vivo, especially in patients with early-stage cancers, the identification of metastatic seeds, and the development of therapeutics for their eradication.
Insights
Preventing cancer metastasis, the spread of tumor cells, is crucial for survival. This review explores targeting metastasis causes and roots, highlighting challenges and opportunities for effective anticancer therapies.
Area of Science:
- Oncology
- Cancer Metastasis Research
Background:
- Metastasis, the spread of tumor cells, is the primary cause of cancer-related mortality.
- Effective anticancer therapies must prioritize the prevention of metastatic disease.
Purpose of the Study:
- To review current approaches targeting the causes and roots of metastasis.
- To discuss challenges in metastasis prevention and suggest future directions.
- To emphasize the importance of clinical evaluation for antimetastatic agents.
Main Methods:
- Review of literature on targeting metastasis.
- Discussion of therapeutic strategies for metastasis prevention.
- Analysis of challenges and opportunities in antimetastatic drug development.
Main Results:
- Identified key targets including hypoxia, metabolic changes, tumor microenvironment, angiogenesis, epithelial-mesenchymal transition, migration, and invasion.
- Highlighted limitations of current antimetastatic approaches.
- Proposed strategies to overcome existing challenges.
Conclusions:
- Targeting metastasis causes and roots is essential for improving cancer patient outcomes.
- Clinical evaluation of antimetastatic agents, particularly in early-stage cancers, is critical.
- Further research is needed for identifying metastatic seeds and developing effective eradication therapies.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Preventive Healthcare Services
Cancer

